Active 0 6 0 6 B-chronic_disease
infection 7 16 7 16 I-chronic_disease
or 17 19 17 19 O
antibiotic 20 30 20 30 B-treatment
therapy 31 38 31 38 I-treatment

Active 0 6 39 45 O
vitamin 7 14 46 53 B-treatment
D 15 16 54 55 I-treatment
analogue 17 25 56 64 O
use 26 29 65 68 O
( 30 31 69 70 O
i.e. 31 35 70 74 O
calcitriol 36 46 75 85 B-treatment
, 46 47 85 86 O
paricalcitol 48 60 87 99 B-treatment
, 60 61 99 100 O
doxercalciferol 62 77 101 116 B-treatment
) 77 78 116 117 O

Age 0 3 118 121 B-age
40 4 6 122 124 B-lower_bound
- 6 7 124 125 O
79 7 9 125 127 B-upper_bound
, 9 10 127 128 O
women 11 16 129 134 B-gender
must 17 21 135 139 O
be 22 24 140 142 O
post 25 29 143 147 O
- 29 30 147 148 O
menopausal 30 40 148 158 O

Albumin 0 7 159 166 B-clinical_variable
> 8 9 167 168 O
3.0 10 13 169 172 B-lower_bound
g 14 15 173 174 I-lower_bound
/ 15 16 174 175 I-lower_bound
dL 16 18 175 177 I-lower_bound

BMI 0 3 178 181 B-bmi
< 4 5 182 183 O
40 6 8 184 186 B-upper_bound
kg 9 11 187 189 I-upper_bound
/ 11 12 189 190 I-upper_bound
m2 12 14 190 192 I-upper_bound

CKD 0 3 193 196 B-chronic_disease
stage 4 9 197 202 I-chronic_disease
IIIb 10 14 203 207 I-chronic_disease

Expected 0 8 208 216 O
kidney 9 15 217 223 B-treatment
transplant 16 26 224 234 I-treatment
in 27 29 235 237 O
the 30 33 238 241 O
next 34 38 242 246 B-upper_bound
6 39 40 247 248 I-upper_bound
months 41 47 249 255 I-upper_bound

For 0 3 256 259 O
COMIRB 4 10 260 266 O
15 11 13 267 269 O
- 13 14 269 270 O
0384 14 18 270 274 O
, 18 19 274 275 O
completion 20 30 276 286 O
of 31 33 287 289 O
the 34 37 290 293 O
prospective 38 49 294 305 O
, 49 50 305 306 O
randomized 51 61 307 317 O
, 61 62 317 318 O
placebo 63 70 319 326 O
- 70 71 326 327 O
controlled 71 81 327 337 O
double 82 88 338 344 O
- 88 89 344 345 O
blind 89 94 345 350 O
trial 95 100 351 356 O
, 100 101 356 357 O
Phosphorus 102 112 358 368 O
Lowering 113 121 369 377 O
to 122 124 378 380 O
Treat 125 130 381 386 O
Vascular 131 139 387 395 B-chronic_disease
Dysfunction 140 151 396 407 I-chronic_disease
in 152 154 408 410 O
Chronic 155 162 411 418 B-chronic_disease
Kidney 163 169 419 425 I-chronic_disease
Disease 170 177 426 433 I-chronic_disease
( 178 179 434 435 O
COMIRB 179 185 435 441 O
13 186 188 442 444 O
- 188 189 444 445 O
0328 189 193 445 449 O
) 193 194 449 450 O
or 195 197 451 453 O
completion 198 208 454 464 O
of 209 211 465 467 O
12 212 214 468 470 B-upper_bound
- 214 215 470 471 I-upper_bound
week 215 219 471 475 I-upper_bound
run 220 223 476 479 O
- 223 224 479 480 O
in 224 226 480 482 O
phase 227 232 483 488 O

History 0 7 489 496 O
of 8 10 497 499 O
congestive 11 21 500 510 B-chronic_disease
heart 22 27 511 516 I-chronic_disease
failure 28 35 517 524 I-chronic_disease
( 36 37 525 526 O
EF 37 39 526 528 B-clinical_variable
< 40 41 529 530 O
35 42 44 531 533 B-upper_bound
% 44 45 533 534 I-upper_bound
) 45 46 534 535 O

History 0 7 536 543 O
of 8 10 544 546 O
hospitalizations 11 27 547 563 O
within 28 34 564 570 O
the 35 38 571 574 O
last 39 43 575 579 B-upper_bound
3 44 45 580 581 I-upper_bound
months 46 52 582 588 I-upper_bound

History 0 7 589 596 O
of 8 10 597 599 O
ileus 11 16 600 605 B-chronic_disease
or 17 19 606 608 O
bowel 20 25 609 614 B-chronic_disease
obstruction 26 37 615 626 I-chronic_disease

History 0 7 627 634 O
of 8 10 635 637 O
severe 11 17 638 644 O
liver 18 23 645 650 B-chronic_disease
disease 24 31 651 658 I-chronic_disease

IV 0 2 659 661 O
( 3 4 662 663 O
estimated 4 13 663 672 B-clinical_variable
glomerular 14 24 673 683 I-clinical_variable
filtration 25 35 684 694 I-clinical_variable
rate 36 40 695 699 I-clinical_variable
by 41 43 700 702 O
MDRD 44 48 703 707 O
15 49 51 708 710 B-lower_bound
- 51 52 710 711 O
45 52 54 711 713 B-upper_bound
mL 55 57 714 716 I-upper_bound
/ 57 58 716 717 I-upper_bound
min/1.73m2 58 68 717 727 I-upper_bound
) 68 69 727 728 O
, 69 70 728 729 O
stable 71 77 730 736 O
for 78 81 737 740 O
3 82 83 741 742 B-upper_bound
months 84 90 743 749 I-upper_bound

Life 0 4 750 754 B-clinical_variable
expectancy 5 15 755 765 I-clinical_variable
< 16 17 766 767 O
1 17 18 767 768 B-upper_bound
year 19 23 769 773 I-upper_bound

Not 0 3 774 777 O
taking 4 10 778 784 O
medications 11 22 785 796 B-treatment
that 23 27 797 801 O
interact 28 36 802 810 O
with 37 41 811 815 O
agents 42 48 816 822 O
administered 49 61 823 835 O
during 62 68 836 842 O
experimental 69 81 843 855 O
sessions 82 90 856 864 O
( 91 92 865 866 O
e.g. 92 96 866 870 O
, 96 97 870 871 O
sildenafil 98 108 872 882 B-treatment
interacts 109 118 883 892 O
with 119 123 893 897 O
nitroglycerin 124 137 898 911 B-treatment
) 137 138 911 912 O

Not 0 3 913 916 O
using 4 9 917 922 O
phosphate 10 19 923 932 B-treatment
binders 20 27 933 940 I-treatment

Serum 0 5 941 946 B-clinical_variable
phosphorus 6 16 947 957 I-clinical_variable
2.8 17 20 958 961 B-lower_bound
- 20 21 961 962 O
5.5 21 24 962 965 B-upper_bound
mg 25 27 966 968 I-upper_bound
/ 27 28 968 969 I-upper_bound
dL 28 30 969 971 I-upper_bound
, 30 31 971 972 O
stable 32 38 973 979 O
for 39 42 980 983 O
3 43 44 984 985 B-upper_bound
months 45 51 986 992 I-upper_bound

Uncontrolled 0 12 993 1005 O
hypertension 13 25 1006 1018 B-chronic_disease

Vasculitis 0 10 1019 1029 B-chronic_disease
requiring 11 20 1030 1039 O
immunosuppressive 21 38 1040 1057 B-treatment
therapy 39 46 1058 1065 I-treatment
within 47 53 1066 1072 O
the 54 57 1073 1076 O
last 58 62 1077 1081 B-upper_bound
year 63 67 1082 1086 I-upper_bound

